BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Lu D, Zhuo J, Lin Z, Yang M, Xu X. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases. Int J Biol Sci 2020;16:2357-66. [PMID: 32760203 DOI: 10.7150/ijbs.46405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Song W, Sun LY, Zhu ZJ. Effects of Previous Kasai Surgery on Gut Microbiota and Bile Acid in Biliary Atresia With End-Stage Liver Disease. Front Med (Lausanne) 2021;8:704328. [PMID: 34646837 DOI: 10.3389/fmed.2021.704328] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li M, Zhao X, Xie J, Tong X, Shan J, Shi M, Wang G, Ye W, Liu Y, Unger BH, Cheng Y, Zhang W, Wu N, Xia X. Dietary Inclusion of Seabuckthorn (Hippophae rhamnoides) Mitigates Foodborne Enteritis in Zebrafish Through the Gut-Liver Immune Axis. Front Physiol 2022;13:831226. [DOI: 10.3389/fphys.2022.831226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hild B, Heinzow HS, Schmidt HH, Maschmeier M. Bile Acids in Control of the Gut-Liver-Axis. Z Gastroenterol 2021;59:63-8. [PMID: 33429452 DOI: 10.1055/a-1330-9644] [Reference Citation Analysis]
4 Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, Azimirad M, Alavifard H, Mohsenifar Z, Davari M, Vaziri F, Moshiri A, Siadat SD, Zali MR. The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury. Microbiol Spectr 2021;9:e0048421. [PMID: 34549998 DOI: 10.1128/Spectrum.00484-21] [Reference Citation Analysis]
5 Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives. Front Psychiatry 2022;13:880568. [PMID: 35546942 DOI: 10.3389/fpsyt.2022.880568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen H, Lu D, Yang X, Hu Z, He C, Li H, Lin Z, Yang M, Xu X. One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma. Front Immunol 2022;13:879552. [PMID: 35634295 DOI: 10.3389/fimmu.2022.879552] [Reference Citation Analysis]
7 Yuan M, Lin L, Cao H, Zheng W, Wu L, Zuo H, Tian X, Song H. Intestinal Microbiota Participates in the Protective Effect of HO-1/BMMSCs on Liver Transplantation With Steatotic Liver Grafts in Rats. Front Microbiol 2022;13:905567. [PMID: 35756057 DOI: 10.3389/fmicb.2022.905567] [Reference Citation Analysis]
8 Chen L, Zhu Y, Hou X, Yang L, Chu H. The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease. Front Med 2022;9:840752. [DOI: 10.3389/fmed.2022.840752] [Reference Citation Analysis]
9 Gebru YA, Gupta H, Kim HS, Eom JA, Kwon GH, Park E, Jeong JJ, Won SM, Sharma SP, Ganesan R, Kim DJ, Suk KT. T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:12190. [PMID: 34830072 DOI: 10.3390/ijms222212190] [Reference Citation Analysis]
10 Shen H, Zhao Z, Zhao Z, Chen Y, Zhang L. Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases. Int J Mol Sci 2022;23:594. [PMID: 35054790 DOI: 10.3390/ijms23020594] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Chen MY, Yadav VK, Chu YC, Ong JR, Huang TY, Lee KF, Lee KH, Yeh CT, Lee WH. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers (Basel) 2021;13:3227. [PMID: 34203465 DOI: 10.3390/cancers13133227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Chen J, Wang Y, Shi Y, Liu Y, Wu C, Luo Y. Association of Gut Microbiota With Intestinal Ischemia/Reperfusion Injury. Front Cell Infect Microbiol 2022;12:962782. [DOI: 10.3389/fcimb.2022.962782] [Reference Citation Analysis]
13 Saeed NK, Al-Beltagi M, Bediwy AS, El-Sawaf Y, Toema O. Gut microbiota in various childhood disorders: Implication and indications. World J Gastroenterol 2022; 28(18): 1875-1901 [DOI: 10.3748/wjg.v28.i18.1875] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 D'Onofrio F, Renga G, Puccetti M, Pariano M, Bellet MM, Santarelli I, Stincardini C, Mosci P, Ricci M, Giovagnoli S, Costantini C, Romani L. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis. Cells 2021;10:1622. [PMID: 34209524 DOI: 10.3390/cells10071622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Zhang B, Zhao J, Jiang M, Peng D, Dou X, Song Y, Shi J. The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment. Front Immunol 2022;13:893617. [PMID: 35634340 DOI: 10.3389/fimmu.2022.893617] [Reference Citation Analysis]
16 Gupta H, Min B, Ganesan R, Gebru YA, Sharma SP, Park E, Won S, Jeong J, Lee S, Cha M, Kwon G, Jeong M, Hyun J, Eom J, Park H, Yoon S, Choi M, Kim D, Suk K. Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role. Biomedicines 2022;10:550. [DOI: 10.3390/biomedicines10030550] [Reference Citation Analysis]
17 Chen T, Li R, Chen P. Gut Microbiota and Chemical-Induced Acute Liver Injury. Front Physiol 2021;12:688780. [PMID: 34122150 DOI: 10.3389/fphys.2021.688780] [Reference Citation Analysis]
18 Liu H, Xu J, Li H, Zhang L, Xu P. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease. Anat Rec (Hoboken) 2021;304:2605-19. [PMID: 34536264 DOI: 10.1002/ar.24770] [Reference Citation Analysis]
19 Zeng S, Schnabl B. Roles for the mycobiome in liver disease. Liver Int 2022. [PMID: 34995410 DOI: 10.1111/liv.15160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yang T, Yang S, Zhao J, Wang P, Li S, Jin Y, Liu Z, Zhang X, Zhang Y, Zhao Y, Liao J, Li S, Hua K, Gu Y, Wang D, Huang J. Comprehensive Analysis of Gut Microbiota and Fecal Bile Acid Profiles in Children With Biliary Atresia. Front Cell Infect Microbiol 2022;12:914247. [DOI: 10.3389/fcimb.2022.914247] [Reference Citation Analysis]
21 Fu Y, He Y, Xiang K, Zhao C, He Z, Qiu M, Hu X, Zhang N. The Role of Rumen Microbiota and Its Metabolites in Subacute Ruminal Acidosis (SARA)-Induced Inflammatory Diseases of Ruminants. Microorganisms 2022;10:1495. [PMID: 35893553 DOI: 10.3390/microorganisms10081495] [Reference Citation Analysis]
22 Won SM, Park E, Jeong JJ, Ganesan R, Gupta H, Gebru YA, Sharma S, Kim DJ, Suk KT. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. Int J Mol Sci 2021;22:8309. [PMID: 34361075 DOI: 10.3390/ijms22158309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Liu Y, Baba Y, Ishimoto T, Gu X, Zhang J, Nomoto D, Okadome K, Baba H, Qiu P. Gut microbiome in gastrointestinal cancer: a friend or foe? Int J Biol Sci 2022;18:4101-17. [PMID: 35844804 DOI: 10.7150/ijbs.69331] [Reference Citation Analysis]
24 Silveira MAD, Bilodeau S, Greten TF, Wang XW, Trinchieri G. The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis. Trends Cancer 2022:S2405-8033(22)00045-0. [PMID: 35331674 DOI: 10.1016/j.trecan.2022.02.009] [Reference Citation Analysis]